225 related articles for article (PubMed ID: 28330694)
1. CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma.
Xing Y; Wen X; Ding X; Fan J; Chai P; Jia R; Ge S; Qian G; Zhang H; Fan X
Mol Ther; 2017 May; 25(5):1209-1221. PubMed ID: 28330694
[TBL] [Abstract][Full Text] [Related]
2. PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma.
Ding X; Wang X; Lin M; Xing Y; Ge S; Jia R; Zhang H; Fan X; Li J
FEBS Lett; 2016 Jun; 590(12):1729-38. PubMed ID: 27214741
[TBL] [Abstract][Full Text] [Related]
3. ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma.
Xu S; Wang H; Pan H; Shi Y; Li T; Ge S; Jia R; Zhang H; Fan X
Cancer Lett; 2016 Oct; 381(1):41-8. PubMed ID: 27461581
[TBL] [Abstract][Full Text] [Related]
4. The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression.
Lu L; Yu X; Zhang L; Ding X; Pan H; Wen X; Xu S; Xing Y; Fan J; Ge S; Zhang H; Jia R; Fan X
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124977
[TBL] [Abstract][Full Text] [Related]
5. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
[TBL] [Abstract][Full Text] [Related]
6.
Li P; He J; Yang Z; Ge S; Zhang H; Zhong Q; Fan X
Autophagy; 2020 Jul; 16(7):1186-1199. PubMed ID: 31462126
[TBL] [Abstract][Full Text] [Related]
7. CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma.
Xing Y; Wen X; Ding X; Fan J; Chai P; Jia R; Ge S; Qian G; Zhang H; Fan X
Mol Ther; 2023 Sep; 31(9):2811. PubMed ID: 37634510
[No Abstract] [Full Text] [Related]
8. LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter.
Ni H; Chai P; Yu J; Xing Y; Wang S; Fan J; Ge S; Wang Y; Jia R; Fan X
Cell Death Dis; 2020 May; 11(5):306. PubMed ID: 32366932
[TBL] [Abstract][Full Text] [Related]
9. P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma.
Pan H; Ni H; Zhang L; Xing Y; Fan J; Li P; Li T; Jia R; Ge S; Zhang H; Fan X
Tumour Biol; 2016 Oct; 37(10):13533-13543. PubMed ID: 27468714
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation.
Wu S; Chen H; Han N; Zhang C; Yan H
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4904-4914. PubMed ID: 31770435
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXA11-AS Exerts Oncogenic Functions by Repressing p21 and miR-124 in Uveal Melanoma.
Lu Q; Zhao N; Zha G; Wang H; Tong Q; Xin S
DNA Cell Biol; 2017 Oct; 36(10):837-844. PubMed ID: 28749709
[TBL] [Abstract][Full Text] [Related]
12. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Analysis of Uveal Melanoma Metastasis-Associated LncRNAs and Their Functional Network.
Xu B; Ma R; Ren H; Qian J
DNA Cell Biol; 2018 Feb; 37(2):99-108. PubMed ID: 29240458
[TBL] [Abstract][Full Text] [Related]
14. LncRNA PVT1 knockdown affects proliferation and apoptosis of uveal melanoma cells by inhibiting EZH2.
Huang XM; Shi SS; Jian TM; Tang DR; Wu T; Sun FY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2880-2887. PubMed ID: 31002139
[TBL] [Abstract][Full Text] [Related]
15. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
[TBL] [Abstract][Full Text] [Related]
16. LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway.
Liu B; Yao X; Zhang C; Li W; Wang Y; Liao Q; Li Z; Huang Q; Zhang Y; Wu W
Oxid Med Cell Longev; 2023; 2023():8994901. PubMed ID: 36713034
[TBL] [Abstract][Full Text] [Related]
17. Antitumor efficacy of VP22-CD/5-FC suicide gene system mediated by lentivirus in a murine uveal melanoma model.
Liu S; Song W; Liu F; Zhang J; Zhu S
Exp Eye Res; 2018 Jul; 172():144-151. PubMed ID: 29660328
[TBL] [Abstract][Full Text] [Related]
18. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
[TBL] [Abstract][Full Text] [Related]
19. Targeting Epigenetic Modifications in Uveal Melanoma.
Chokhachi Baradaran P; Kozovska Z; Furdova A; Smolkova B
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32726977
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor.
Wang Y; Liu M; Jin Y; Jiang S; Pan J
Cancer Lett; 2017 Aug; 400():47-60. PubMed ID: 28455241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
